BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules November 9, 2023 GlobeNewswire Source: Medical Share on Facebook Share Share on TwitterTweet Share on Google Plus Share Share on Pinterest Share Share on LinkedIn Share Share on Digg Share